DUE: February 28, 2024 This Concept supports clinical studies applications to study psychedelic treatment administration paradigms, assess the role of psychotherapy in its administration, and describe and assess the range of clinical outcomes, including downstream Read More
DUE: February 22, 2024 The purpose of this NOFO is to provide support for applications for IND-enabling studies for the development of a novel in vivo genome editing therapeutic platform (genome editor plus delivery system) Read More
DUE: February 20, 2024 This RFA will solicit applications for a pivotal phase 3 clinical trial to determine the efficacy of FDA approved monoclonal antibody therapy compared to placebo in diverse “mixed dementia” populations with Read More
DUE: February 16, 2024 The 2023 update to theNational Artificial Intelligence Research and Development Strategic Plan,informed by visioning activities in the scientific community as well as interaction with the public, identifies as its first strategic Read More
DUE: February 15, 2024 \This FOA is a key element of NIMHs set of FOAs to support clinical trials research across the intervention development and testing pipeline. The FOA supports (1) clinical trials to test Read More
DUE: February 15, 2024 NIMH requires an experimental therapeutics approach for the development and testing of therapeutic interventions, in which studies both evaluate the clinical effect of an intervention and generate information about the mechanisms Read More
DUE: February 15, 2024 This Notice of Funding Opportunity (NOFO) invites U54 Cooperative Agreement applications aiming to establish multi-component Alzheimers Disease and Related Dementias Translational Centers for Microphysiological Systems (MPS) (AD/ADRD MPS Translational Centers). The Read More
DUE: February 8, 2024 The goal of this NOFO is to support the development and application of innovative ex-vivo imaging methods, along with necessary tissue procurement, processing and computation pipelines, to enable the spatial analysis Read More
DUE: February 1, 2024 The aim of the PAC program is to support empirically grounded, theoretically engaged and methodologically sophisticated research in a wide range of topic areas related to human perceptual, motor, and cognitive Read More
DUE: February 1, 2024 The Cognitive Neuroscience (CogNeuro) Program seeks to fund proposals that can advance our understanding of the neural mechanisms underlying human cognition and behavior.
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.